Gladell P. Paner to Risk Assessment
This is a "connection" page, showing publications Gladell P. Paner has written about Risk Assessment.
Connection Strength
0.320
-
Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer. Cells. 2020 09 17; 9(9).
Score: 0.107
-
Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging Scenarios. Surg Pathol Clin. 2018 Dec; 11(4):775-795.
Score: 0.095
-
Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum. Virchows Arch. 2018 Jul; 473(1):85-93.
Score: 0.091
-
Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6. Int J Clin Exp Pathol. 2012; 5(6):496-502.
Score: 0.015
-
Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancer. Prostate. 2007 Oct 01; 67(14):1524-36.
Score: 0.011